Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q1 2022 · 10-Q
Revenue$53.11M$53.11M+32.1% vs Q1 2021 Net Income-$94.62M-$94.62MN/M vs Q1 2021 EPS Diluted-$0.80-$0.80N/M vs Q1 2021 Operating Income-$89,833,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
Free Cash Flowderived-$106,862,000N/M Margins · derivedOperating margin-169.2%+39.3 pt vs Q1 2021
Net margin-178.2%+49.7 pt vs Q1 2021
ended Mar 31, 2022 · filed May 5, 2022 · 35 d after period end